Evidence map›Paper›PMID 36685544›Full record

ArticleFrontiers in immunology2022

Corrigendum: Reliable estimation of CD8 T cell inhibition of

Yinyan Xu, Ann Marie Weideman, Maria Abad-Fernandez, Katie R Mollan, Sallay Kallon, Shahryar Samir, Joanna A Warren, Genevieve Clutton, Nadia R Roan, Adaora A Adimora and 5 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in immunology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

15 authors.

Yinyan XuDepartment of Microbiology & Immunology, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC, United States.
Ann Marie WeidemanDepartment of Biostatistics, University of North Carolina at Chapel Hill, Chapel Hill, NC, United States.
Maria Abad-FernandezDepartment of Microbiology & Immunology, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC, United States.
Katie R MollanCenter for AIDS Research, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, United States.
Sallay KallonDepartment of Microbiology & Immunology, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC, United States.
Shahryar SamirDepartment of Microbiology & Immunology, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC, United States.
Joanna A WarrenDepartment of Microbiology & Immunology, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC, United States.
Genevieve CluttonDepartment of Microbiology & Immunology, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC, United States.
Nadia R RoanDepartment of Urology, University of California San Francisco, San Francisco, CA, United States.
Adaora A AdimoraCenter for AIDS Research, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, United States.
Nancie ArchinSchool of Medicine and UNC HIV Cure Center, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC, United States.
JoAnn KurucSchool of Medicine and UNC HIV Cure Center, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC, United States.
Cynthia GaySchool of Medicine and UNC HIV Cure Center, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC, United States.
Michael G HudgensDepartment of Biostatistics, University of North Carolina at Chapel Hill, Chapel Hill, NC, United States.
Nilu GoonetillekeDepartment of Microbiology & Immunology, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC, United States.

Funding

UNC MACS/WIHS Combined Cohort Study Clinical Research SiteU01HL146194 · NHLBI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Michael Bradley Drummond, Michelle Floris-Moore · 2019 to 2026
$23.2M
Biostatistics for Research in Genomics and CancerT32CA106209 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI JOSEPH G IBRAHIM, Naim Ur Rashid · 2004 to 2026
$4.8M
NCI NIH HHS T32 CA106209NHLBI NIH HHS U01 HL146194
6 · The paper itself

Abstract

[This corrects the article DOI: 10.3389/fimmu.2021.666991.].

Indexed as

CD4CD8HIVJRCSFp24ROCT-cellVIA

Identifiers

PMID36685544
PMCPMC9846844

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.